Tetralogy of Fallot

References

Key articles

Valente AM, Cook S, Festa P, et al. Multimodality imaging guidelines for patients with repaired tetralogy of Fallot: a report from the American Society of Echocardiography: developed in collaboration with the Society for Cardiovascular Magnetic Resonance and the Society for Pediatric Radiology. J Am Soc Echocardiogr. 2014 Feb;27(2):111-41. Abstract

Hirsch JC, Mosca RS, Bove EL. Complete repair of tetralogy of Fallot in the neonate: results in the modern era. Ann Surg. 2000 Oct;232(4):508-14.Full text  Abstract

Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC guidelines for the management of infective endocarditis. Eur Heart J. 2015 Nov 21;36(44):3075-128.Full text  Abstract

Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2019 Apr 2;139(14):e698-800.Full text  Abstract

Lui GK, Saidi A, Bhatt AB, et al. Diagnosis and management of noncardiac complications in adults with congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2017 Nov 14;136(20):e348-92.Full text  Abstract

Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC guidelines for the management of adult congenital heart disease. Eur Heart J. 2021 Feb 11;42(6):563-645.Full text  Abstract

Reference articles

1. Allen HD, Driscoll DJ, Shaddy RE, et al. Moss and Adams’ heart disease in infants, children, and adolescents: including the fetus and young adult. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007.

2. Ferencz C, Rubin JD, McCarter RJ, et al. Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study. Am J Epidemiol. 1985 Jan;121(1):31-6. Abstract

3. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002 Jun 19;39(12):1890-900.Full text  Abstract

4. Bailliard F, Anderson RH. Tetralogy of Fallot. Orphanet J Rare Dis. 2009 Jan 13;4:2.Full text  Abstract

5. Centers for Disease Control and Prevention. Congenital heart defects. Facts about tetralogy of fallot. Feb 2023 [internet publication].Full text

6. Gill H, Splitt M, Sharland GK, et al. Patterns of recurrence of congenital heart disease: an analysis of 6640 consecutive pregnancies evaluated by detailed fetal echocardiography. J Am Coll Cardiol. 2003 Sep 3;42(5):923-9. Abstract

7. Ferencz C, Correa-Villasenor A, Loffredo CA, et al. Malformations of the cardiac outflow tract. In: Ferencz C, Correa-Villasenor A, Loffredo CA, et al, eds. Genetic and environmental risk factors of major cardiovascular malformations: the Baltimore-Washington Infant Study: 1981-1989. Armonk, NY: Futura Publishing Co Inc; 1997:59-102.

8. Kessler-Icekson G, Birk E, Weintraub AY, et al. Association of tetralogy of Fallot with a distinct region of del22q11.2. Am J Med Genet. 2002 Feb 1;107(4):294-8. Abstract

9. Momma K, Kondo C, Ando M, et al. Tetralogy of Fallot associated with chromosome 22q11 deletion. Am J Cardiol. 1995 Sep 15;76(8):618-21. Abstract

10. Li L, Krantz ID, Deng Y, et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet. 1997 Jul;16(3):243-51. Abstract

11. Krantz ID, Smith R, Colliton RP, et al. Jagged1 mutations in patients ascertained with isolated congenital heart defects. Am J Med Genet. 1999 May 7;84(1):56-60. Abstract

12. Goldmuntz E, Geiger E, Benson DW. NKX2.5 mutations in patients with tetralogy of Fallot. Circulation. 2001 Nov 20;104(21):2565-8. Abstract

13. Vrijheid M, Martinez D, Manzanares S, et al. Ambient air pollution and risk of congenital anomalies: a systematic review and meta-analysis. Environ Health Perspect. 2011 May;119(5):598-606. Abstract

14. Koch R, Levy HL, Matalon R, et al. The North American Collaborative Study of Maternal Phenylketonuria. Status report 1993. Am J Dis Child. 1993 Nov;147(11):1224-30. Abstract

15. Lammer EJ, Chen DT, Hoar RM, et al. Retinoic acid embryopathy. N Engl J Med. 1985 Oct 3;313(14):837-41. Abstract

16. Feldman GL, Weaver DD, Lovrien EW. The fetal trimethadione syndrome: report of an additional family and further delineation of this syndrome. Am J Dis Child. 1977 Dec;131(12):1389-92. Abstract

17. Kothari SS. Mechanism of cyanotic spells in tetralogy of Fallot - the missing link? Int J Cardiol. 1992 Oct;37(1):1-5. Abstract

18. Reich JD, Miller S, Brogdon B, et al. The use of pulse oximetry to detect congenital heart disease. J Pediatr. 2003 Mar;142(3):268-72. Abstract

19. Rosati E, Chitano G, Dipaola L, et al. Indications and limitations for a neonatal pulse oximetry screening of critical congenital heart disease. J Perinat Med. 2005;33(5):455-7. Abstract

20. Frommelt P, Lopez L, Dimas VV, et al. Recommendations for multimodality assessment of congenital coronary anomalies: a guide from the American Society of Echocardiography: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Japanese Society of Echocardiography, and Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2020 Mar;33(3):259-94.Full text  Abstract

21. Dabizzi R, Teodori G, Barletta GA, et al. Associated coronary and cardiac anomalies in the tetralogy of Fallot. An angiographic study. Eur Heart J. 1990 Aug;11(8):692-704. Abstract

22. Qureshi AM, Caldarone CA, Wilder TJ. Transcatheter approaches to palliation for tetralogy of Fallot. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2022;25:48-57. Abstract

23. Kambe T, Kato T, Hibi N, et al. Differential diagnosis of pulmonary stenosis by means of intracardiac phonocardiography. Jpn Heart J. 1976 Nov;17(6):691-705. Abstract

24. Martin GR, Beekman RH 3rd, Mikula EB, et al. Implementing recommended screening for critical congenital heart disease. Pediatrics. 2013 Jul;132(1):e185-92. Abstract

25. Wasserman MA, Shea E, Cassidy C, et al. Recommendations for the adult cardiac sonographer performing echocardiography to screen for critical congenital heart disease in the newborn: from the American Society of Echocardiography. J Am Soc Echocardiogr. 2021 Mar;34(3):207-22.Full text  Abstract

26. Valente AM, Cook S, Festa P, et al. Multimodality imaging guidelines for patients with repaired tetralogy of Fallot: a report from the American Society of Echocardiography: developed in collaboration with the Society for Cardiovascular Magnetic Resonance and the Society for Pediatric Radiology. J Am Soc Echocardiogr. 2014 Feb;27(2):111-41. Abstract

27. Yuan SM, Shinfeld A, Raanani E. The Blalock-Taussig shunt. J Card Surg. 2009 Mar-Apr;24(2):101-8.Full text  Abstract

28. Saxena A, Ramakrishnan S, Tandon R, et al; Working Group on Management of Congenital Heart Diseases in India. Consensus on timing of intervention for common congenital heart diseases. Indian Pediatr. 2008 Feb;45(2):117-26.Full text  Abstract

29. Hirsch JC, Mosca RS, Bove EL. Complete repair of tetralogy of Fallot in the neonate: results in the modern era. Ann Surg. 2000 Oct;232(4):508-14.Full text  Abstract

30. Parry AJ, McElhinney DB, Kung GC, et al. Elective primary repair of acyanotic tetralogy of Fallot in early infancy: overall outcome and impact on the pulmonary valve. J Am Coll Cardiol. 2000 Dec;36(7):2279-83. Abstract

31. Knott-Craig CJ, Elkins RC, Lane MM, et al. A 26-year experience with surgical management of tetralogy of Fallot: risk analysis for mortality or late reintervention. Ann Thorac Surg. 1998 Aug;66(2):506-11. Abstract

32. Oosterhof T, van Straten A, Vliegen HW, et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation. 2007 Jul 31;116(5):545-51.Full text  Abstract

33. Therrien J, Provost Y, Merchant N, et al. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol. 2005 Mar 15;95(6):779-82. Abstract

34. Geva T. Indications and timing of pulmonary valve replacement after tetralogy of Fallot repair. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2006:11-22. Abstract

35. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC guidelines for the management of infective endocarditis. Eur Heart J. 2015 Nov 21;36(44):3075-128.Full text  Abstract

36. Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC guidelines for the management of endocarditis. Eur Heart J. 2023 Oct 14;44(39):3948-4042.Full text  Abstract

37. Khambadkone S, Coats L, Taylor A, et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation. 2005 Aug 23;112(8):1189-97.Full text  Abstract

38. American College of Radiology. ACR Appropriateness Criteria® congenital or acquired heart disease. 2023 [internet publication].Full text

39. Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2019 Apr 2;139(14):e698-800.Full text  Abstract

40. Lui GK, Saidi A, Bhatt AB, et al. Diagnosis and management of noncardiac complications in adults with congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2017 Nov 14;136(20):e348-92.Full text  Abstract

41. Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC guidelines for the management of adult congenital heart disease. Eur Heart J. 2021 Feb 11;42(6):563-645.Full text  Abstract

42. Abbott ME. Atlas of congenital cardiac disease. New York, NY: American Heart Association; 1936.

43. Nollert G, Fischlein T, Bouterwek S, et al. Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol. 1997 Nov 1;30(5):1374-83. Abstract

44. Nollert G, Däbritz SH, Schmoeckel M, et al. Risk factors for sudden death after repair of tetralogy of Fallot. Ann Thorac Surg. 2003 Dec;76(6):1901-5. Abstract

45. Silka M, Hardy BG, Menashe VD, et al. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol. 1998 Jul;32(1):245-51. Abstract

46. Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000 Sep 16;356(9234):975-81. Abstract

47. Daliento L, Rizzoli G, Menti L, et al. Accuracy of electrocardiographic and echocardiographic indices in predicting life threatening ventricular arrhythmias in patients operated for tetralogy of Fallot. Heart. 1999 Jun;81(6):650-5.Full text  Abstract

48. Gatzoulis MA, Till JA, Somerville J, et al. Mechanoelectrical interaction in tetralogy of Fallot: QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995 Jul 15;92(2):231-7. Abstract

49. Krieger EV, Zeppenfeld K, DeWitt ES, et al. Arrhythmias in repaired tetralogy of Fallot: a scientific statement from the American Heart Association. Circ Arrhythm Electrophysiol. 2022 Nov;15(11):e000084.Full text  Abstract

50. Roos-Hesselink J, Perlroth MG, McGhie J, et al. Atrial arrhythmias in adults after repair of tetralogy of Fallot. Correlations with clinical, exercise, and echocardiographic findings. Circulation. 1995 Apr 15;91(8):2214-9. Abstract

51. Geva T, Sandweiss BM, Gauvreau K, et al. Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging. J Am Coll Cardiol. 2004 Mar 17;43(6):1068-74. Abstract

52. Lisanti AJ, Uzark KC, Harrison TM, et al. Developmental care for hospitalized infants with complex congenital heart disease: a science advisory from the American Heart Association. J Am Heart Assoc. 2023 Feb 7;12(3):e028489.Full text  Abstract

53. Sood E, Newburger JW, Anixt JS, et al. Neurodevelopmental outcomes for individuals with congenital heart disease: updates in neuroprotection, risk-stratification, evaluation, and management: a scientific statement from the American Heart Association. Circulation. 2024 Mar 26;149(13):e997-1022.Full text  Abstract

54. Canobbio MM, Warnes CA, Aboulhosn J, et al; American Heart Association. Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2017 Feb 21;135(8):e50-87.Full text  Abstract

55. John AS, Jackson JL, Moons P, et al. Advances in managing transition to adulthood for adolescents with congenital heart disease: a practical approach to transition program design: a scientific statement from the American Heart Association. J Am Heart Assoc. 2022 Apr 5;11(7):e025278.Full text  Abstract

56. Siu SC, Colman JM. Heart disease and pregnancy. Heart. 2001 Jun;85(6):710-5.Full text  Abstract

Use of this content is subject to our disclaimer